News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Mehmet Ali Nahit Sendur

Articles by Mehmet Ali Nahit Sendur

TPS 38 ELCIN: Elacestrant in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer: An Open-Label, Multicenter, Phase 2 Study

ByVirginia Kaklamani, MD, DSc,Giorgi Dzagnidze,Nicoleta Zenovia Antone,Anu Thummala,Mikheil Janjalia,Patricia Santi,Carlos Barrios,Mehmet Ali Nahit Sendur,Xiaoling Zhang,Angela Gambioli,Manuel Dominguez,Kathy Puyana Theall,Tomer Wasserman,William J. Gradishar, MD

June 12th 2025

Latest Updated Articles

Trending on CancerNetwork

Obesity and Cancer Risk: The Evolving Role of GLP-1s in Oncology

FDA Approves Afami-cel in Metastatic Synovial Sarcoma

Exploring The Future of Artificial Intelligence and Thoracic Oncology

EC Approves Encorafenib/Cetuximab/FOLFOX in 1L BRAF V600E–Mutant mCRC

Binimetinib Tablets Receive Tentative FDA Approval in Melanoma/NSCLC